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(2014) provide mechanistic insight into
the response of melanocytes to oxida-
tive stress and their role in the patho-
genesis of vitiligo. This study opens the
possibility that the Nrf2–ARE pathway
could be exploited as a preventive and/
or therapeutic strategy to counter oxida-
tive damage in melanocytes, as well as
to dampen IL-2 production.
There are several limitations to this
study, specifically as it relates to mela-
nocytes in vivo and the potential for
clinical translation. First, the melano-
cytes used in this study are immortalized
cell lines, which may exhibit altered
oxidative stress responses compared
with primary melanocytes. Immunohis-
tochemical evaluation of the levels/loca-
lization of Nrf2 and/or antioxidant
enzymes in normal and lesional skin
will be of considerable value. This will
also address the role of keratinocyte
antioxidant responses in vitiligo patho-
genesis, as keratinocytes are thought to
be ROS donors to melanocytes. Second,
although H2O2 is a widely used and
widely accepted oxidative stress indu-
cer, additional stressors may need to
be tested to confirm the role of the
Nrf2–ARE pathway. Third, although pro-
vocative, the observations on the inverse
relationship between serum HO-1 and
IL-2 levels do not identify the source of
HO-1 (melanocyte intracellular vs. sys-
temically derived) or the correlations
among serum HO-1, IL-2 levels, and
lesional T lymphocyte accumulation.
These limitations notwithstanding, this
study by Jian et al. (2014) shines a
spotlight on antioxdative mechanisms
in vitiligo and highlights the need to
explore strategies to restore a balanced
redox system, thereby protecting
melanocytes from destruction.
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Nagashima-Type Palmoplantar
Keratosis: A Common Asian Type
Caused by SERPINB7 Protease
Inhibitor Deficiency
Akiharu Kubo1
Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive diffuse
non-epidermolytic palmoplantar keratosis caused by mutations in SERPINB7, a
member of the serine protease inhibitor superfamily. Genetic studies suggest that
NPPK is the most common palmoplantar keratosis in Japan, and probably Asia,
but one that is extremely rare in Western countries. In this issue, Yin et al. report a
founder effect of a SERPINB7 mutation in Chinese populations.
Journal of Investigative Dermatology (2014) 134, 2076–2079. doi:10.1038/jid.2014.156
Establishment of a new entity of
palmoplantar keratosis
Nagashima-type palmoplantar keratosis
(NPPK; MIM 615598) is a comparatively
new entity of palmoplantar keratosis
(PPK). Masaji Nagashima first described
this disease briefly in 1977 as a form of
PPK showing a similar distribution of
lesions to, but a considerably milder
disease phenotype than, Mal de Meleda
(MIM 248300) (Nagashima, 1977). Inde-
pendently, Mitsuhashi and Hashimato
(1989) observed a Japanese patient who
had reddish diffuse mild PPK extending
to the dorsal surfaces of the hands and
feet. Together with UW Schnyder, a
Swiss specialist in genetic skin diseases
who investigated Mal de Meleda in
the Adriatic island of Mljet (Meleda)
(Schnyder, 1969), they concluded that
the patient’s phenotype was far milder
than that of Mal de Meleda. Ultimately,
they reported siblings with the same
distinct disease phenotype and con-
cluded that the disease was a novel
autosomal recessive PPK, designating it
as ‘‘keratosis palmoplantaris Nagashima’’
(Mitsuhashi and Hashimato, 1989).
Because of its probable very low
prevalence in Western countries, this
disease entity has long been recognized
only in Japan. In 2008, Kabashima et al.
(2008) introduced NPPK to international
societies with a detailed description of
the disease phenotype, and they pro-
posed NPPK as a distinct clinical entity
because of the lack of mutations in the
exonic region of SLURP1, the causa-
tive gene of Mal de Meleda. In 2013,
Kubo et al. (2013) finally identified the
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causative gene mutations as residing in
SERPINB7, a member of the serine
protease inhibitor superfamily, in 13
unrelated Japanese NPPK patients via
exome sequencing, and they established
NPPK as a novel disease entity. As the
major causative mutation, c.796C4T
(p.R266*) in SERPINB7, was found in
8/286 Japanese and Chinese individuals
in the 1000 Genomes Database (http://
browser.1000genomes.org), the mutation
has been proposed to be distributed
widely among Asian populations (Kubo
et al., 2013). In this issue, Yin et al. now
characterize NPPK patients from China,
and they confirm the founder effect of
the c.796C4T mutation in SERPINB7
among a second Asian population.
NPPK is characterized clinically by
well-demarcated reddish, diffuse, and
mild palmoplantar non-epidermolytic
hyperkeratosis that extends to the dorsal
surfaces of the hands and feet, inner
wrists, ankles, and the Achilles tendon
area (Figure 1). High frequencies of
hyperhidrosis on palms and soles and
tinea infection have been noted. The
affected areas and clinical manifes-
tations are non-progressive, which is
the major clinical difference from
Mal de Meleda. The palms and soles
of NPPK patients show a whitish spongy
appearance within 10 minutes of water
exposure specifically in the reddish
hyperkeratotic area (Figure 1c and d;
Kubo et al., 2013; Yin et al., 2014).
A widespread founder mutation in
SERPINB7 causes NPPK as a common
PPK in Asian populations
Whitish changes in the palms and
soles after water exposure have also
been reported in autosomal dominant
Bothnian-type PPK (MIM 600231)
caused by AQP5 mutations. Yin et al.
investigated the seven Chinese PPK
patients with reddish mild hyperkerato-
sis showing whitish spongy changes
after water exposure and showed that
all seven patients had bi-allelic muta-
tions in SERPINB7, but not in AQP5.
Taken together with the fact that 9 cau-
sative mutations in SERPINB7 but no
causative mutations in AQP5 were
found in 286 Japanese and Chinese indi-
viduals in the 1000 Genomes Database,
NPPK is suggested to be more common
than Bothnian-type PPK in Japanese
and Chinese populations. As other
types of PPK have considerably lower
prevalences, NPPK is likely the most
common type of PPK in Asian popu-
lations.
Among SERPINB7 mutations in NPPK,
10 of the 14 alleles of Chinese patients
and 19 of the 26 alleles of Japanese
patients were c.796C4T (Kubo et al.,
2013; Yin et al., 2014). Haplotype
analysis in Chinese patients suggested
that c.796C4T is a founder mutation,
instead of a mutation hotspot (Yin et al.,
2014). The c.796C4T mutation was not
found in 806 individuals of non-Asian
origin in the 1000 Genomes Database
or 12,517 alleles of European-American
and African-American origin in the
NHBLI Exome Variant Server (http://evs.
gs.washington.edu/EVS/). These results
indicates that the c.796C4T mutation
has spread widely among Asian popu-
lations due to its founder effect,
which explains why NPPK is so
common in Japan and probably in
China but has not been reported in
Western countries.
NPPK is a new serpin-related congenital
disease
SERPINB7 is a member of the SERine
Protease INhibitor (Serpin) superfamily.
Human serpins have been divided into
nine clades (A-I). In general, protease
inhibitors are resistant to protease-
dependent degradation. If they are sen-
sitive to proteases, it is not possible for
them to function as protease inhibitors.
As stable as they are, some serpins have
lost their protease inhibitory activities
during the course of evolution, becom-
ing storage proteins. For example, oval-
bumin is a homolog of the clade B
serpins, one that has lost its protease
inhibitory activity. Therefore, clade B
serpins, including SERPINB7, are alter-
natively known as ov-serpins.
There are two major mechanisms
by which mutations in SERPINs cause
congenital diseases. One is that loss
of protease inhibitory activity results in
uncontrolled protease activity and tissue
Figure 1. Clinical appearance of Nagashima-type palmoplantar keratosis. (a, b) ‘‘Transgrediens’’ of the
reddish mild hyperkeratosis on the dorsal surfaces of the feet and Achilles tendon area. (c, d) Whitish
spongy changes on the hands after 10 minutes of water exposure. (d) ‘‘Transgrediens’’ on the dorsal
surfaces of the hands.
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destruction. For example, deficiency of
SERPINF2 (alpha2-antiplasmin) causes a
bleeding disorder through uncontrolled
plasmin activity and fibrinolysis (MIM
262850). The second mechanism is that
formation of protease-resistant hyper-
stable misfolded polymers or aggregates
of mutant serpins in serpin-synthesizing
cells results in cell death and tissue
damage. Such diseases are called ‘‘ser-
pinopathies.’’ For example, familial
encephalopathy with neuroserpin inclu-
sion bodies (MIM 604218) is a serpino-
pathy of SERPINI1 (neuroserpin) in
which neurodegeneration is caused
by aberrant protein processing and
tissue deposition of SERPINI1 mutants.
In some diseases, both mechanisms
are involved. Deficiency of SERPINA1
(alpha1-antitrypsin) causes not only
emphysema through proteolytic lung
damage due to neutrophil elastase
induced by the decreased plasma
alpha1-antitrypsin level but also liver
damage and cirrhosis through forma-
tion of hyperstable polymers of mutant
alpha1-antitrypsin in the endoplasmic
reticulum of liver cells (MIM 613490).
Probable loss of protease inhibitory
activity in SERPINB7 causes NPPK
Clade B serpins are intracellular serpins
that possibly protect cells from exogen-
ous and endogenous protease-mediated
injury. SERPINB7 is expressed in the
cytoplasm of stratum granulosum
cells (Kubo et al., 2013). Although the
target protease of SERPINB7 has not
been identified, the protease inhibitory
activity of SERPINB7 has been demon-
strated by plasmin inhibition assay
(Miyata et al., 2002). In NPPK, inclu-
sion bodies or protein aggregates have
not been detected in the stratum granu-
losum or stratum corneum, suggesting
that formation of mutated SERPINB7
polymers does not occur in NPPK
patient skin. The reactive site loop indis-
pensable for protease inhibitory activity
is located at the C-terminus of SERPINB7
and is absent in all of the identified
mutants due to the introduction of pre-
mature stop codons by nonsense, frame-
shift, or splice-site mutations. Therefore,
NPPK is presumably caused by the loss
of protease inhibitory activity of, and not
polymer formation by, SERPINB7 in the
epidermis.
A widespread founder
mutation in SERPINB7
causes NPPK as a
common PPK in Asian
populations.
One of the characteristics of NPPK is
the distribution of the reddish hyper-
keratosis, extending to the dorsal sur-
faces of the hands and feet and Achilles
tendon area, which is known as ‘‘trans-
grediens.’’ SERPINB7 is expressed not
only in palmoplantar skin but also in the
skin of other body areas (Kubo et al.,
2013). In several types of diffuse PPK
with or without associated features,
while the causative gene products
have a widespread expression pattern,
the disease is mostly restricted to the
palmoplantar area. Although the mecha-
nism of this discrepancy is as yet
unknown, such PPKs include Vohwinkel
syndrome (MIM 604117) caused by
loricrin (LOR) mutations, PPK with deaf-
ness (MIM 148350) caused by connexin
26 (GJB2) mutations, and Mal de Meleda
caused by SLURP1 mutations. Interest-
ingly, these PPKs, as well as NPPK, show
‘‘transgrediens’’ to the dorsal surfaces of
the hands and feet. By contrast, PPKs
caused by mutations of palmoplantar-
area-specific genes such as KRT9
(Vo¨rner-type PPK (MIM 144200)) do not
show such ‘‘transgrediens.’’ Future studies
will reveal the factor that restricts the
affected area to the palms and soles
mainly in NPPK, despite widespread
expression of SERPINB7.
Is NPPK caused by imbalance between
proteases and protease inhibitors in skin
homeostasis?
Various proteases, including serine pro-
teases, exist in the stratum granulosum
and the stratum corneum: intracellular
proteases, such as caspase 14, aspartic
peptidase retroviral-like 1/SASPase,
and bleomycin hydrolase responsible
for filaggrin degradation; endolysosomal
proteases, such as cystatins and cathe-
psins; secreted proteases, such as
kallikreins and kallikrein-related pepti-
dases responsible for desquamation;
and transmembrane proteases, such as
matriptase/suppression of tumorigenicity
14 (ST14) and prostatin/protease serine
S1 family member 8 (PRSS8) (Meyer-
Hoffert, 2009; Ovaere et al., 2009).
Additionally, the epidermis is attacked
by various exogenous proteases, origina-
ting from bacteria, fungi, viruses, pollen,
and house dust mites, and endogenous
proteases such as neutrophil elastase and
mast cell chymase, originating from infil-
trating cells. It is likely that the epidermis
expresses various protease inhibitors,
such as LEKTI, LEKTI-2, secretory
leukocyte protease inhibitor, elafin/skin-
derived protease inhibitor, serpins, and
cystatins, to control the activity of these
proteases (Meyer-Hoffert, 2009). LEKTI
deficiency results in Netherton syn-
drome (MIM 256500), in which overacti-
vation of kallikreins and a Par2 signaling
cascade have been demonstrated
(Descargues et al., 2005b; Deraison
et al., 2007; Briot et al., 2009). Studies
of transgenic mice with induced over-
expression of Prss8 or Par2 reported skin
inflammatory responses and ichthyosis
(Frateschi et al., 2011). Knockout
mouse studies targeting proteases (Prss8,
matriptase/St14, and caspase 14) or
protease inhibitors (Spink5/LEKTI and
cystatin E/M) showed skin barrier defi-
ciencies and/or inflammation (List et al.,
2002; Zeeuwen et al., 2002; Leyvraz
et al., 2005; Descargues et al., 2005a;
Denecker et al., 2007). Thus, appropriate
control of the activity of these proteases
is likely important in maintaining skin
homeostasis. However, their regulatory
mechanisms remain mostly unknown.
The discovery of loss-of-function muta-
tions in SERPINB7 in NPPK should
provide insight into the functions and
regulatory mechanisms of proteases and
protease inhibitors in the epidermis.
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